ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.290
-0.250 (-7.06%)
At close: Dec 5, 2025, 4:00 PM EST
3.390
+0.100 (3.04%)
After-hours: Dec 5, 2025, 7:06 PM EST
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $407.56 million as of December 5, 2025. Its market cap has increased by 96.97% in one year.
Market Cap
407.56M
Enterprise Value
630.25M
1-Year Change
96.97%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $407.56M, a decrease of -80.05%. That is a compound annual growth rate of -25.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 438.52M | 127.91% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |